← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-202 | 73702-202-03 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-07 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-098 | 70092-098-44 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:413 | 413 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:413 | 413 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:414 | 414 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-138 | 73198-138-03 | F-9 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:414 | 414 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-052 | 70324-052-01 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-620 | 70004-620-12 | Esmolol Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-837 | 33216-837-04 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:414 | 414 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-415 | 70092-415-47 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-201 | 73702-201-10 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:414 | 414 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:414 | 414 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-9010 | 83863-9010-2 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:414 | 414 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:415 | 415 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-987 | 69374-987-50 | Ropivacaine Hydrochloride 200 mg/100 mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:415 | 415 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clindamycin Phosphate; Spironolactone | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-105 | 73702-105-10 | Esmolol Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-837 | 33216-837-03 | Ephedrine Sulfate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:415 | 415 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-400 | 70092-400-43 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:415 | 415 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:415 | 415 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5010 | 71266-5010-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-444 | 70092-444-05 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:415 | 415 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:416 | 416 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Maintenance 4 to1 Low K (12 meq) in Ringers | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:416 | 416 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Clobetasol Propionate; Zinc Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-925 | 69374-925-10 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1367 | 61141-1367-5 | Esmolol Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:416 | 416 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:416 | 416 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:416 | 416 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:416 | 416 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-099 | 70092-099-49 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-6030 | 83863-6030-1 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:416 | 416 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:417 | 417 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-128 | 73198-128-30 | Hydroxocobalamin 2 mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0420 | 71283-0420-1 | Clonidine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:417 | 417 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:417 | 417 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:417 | 417 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-32 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:417 | 417 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:417 | 417 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:417 | 417 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:418 | 418 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-684 | 70092-684-48 | Fentanyl PF 50 mcg/ml 30 ml syr | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:418 | 418 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2205 | 72627-2205-9 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:418 | 418 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:418 | 418 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-097 | 70092-097-43 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-01 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-15 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:418 | 418 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:418 | 418 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1007 | 73013-1007-1 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:418 | 418 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:419 | 419 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6078 | 71285-6078-1 | Vancomycin 2gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2206 | 72627-2206-9 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-204 | 73702-204-25 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-181 | 69761-181-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-664 | 70092-664-74 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:419 | 419 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-092 | 70092-092-36 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:419 | 419 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:420 | 420 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-006 | 70713-006-01 | TESTOSTERONE SA2 25MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-106 | 73702-106-10 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3020 | 70214-3020-1 | Fentanyl | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-180 | 70092-180-79 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:420 | 420 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-886 | 69194-886-01 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:420 | 420 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:421 | 421 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | ACH | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-106 | 73702-106-15 | Ephedrine Sulfate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-203 | 70004-203-32 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-221 | 69761-221-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:421 | 421 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:421 | 421 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:422 | 422 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0112 | 71285-0112-1 | Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5060 | 71266-5060-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-251 | 69761-251-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-100 | 63037-100-05 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1007 | 73013-1007-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:422 | 422 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:422 | 422 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:423 | 423 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4618 | 72934-4618-3 | Plenura | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar; Salicylic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-910 | 71170-910-25 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5045 | 71266-5045-2 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-061 | 69761-061-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1062 | 73013-1062-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:423 | 423 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:423 | 423 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:424 | 424 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:424 | 424 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar; Salicylic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:424 | 424 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-012 | 69761-012-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:424 | 424 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:424 | 424 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2073 | 71286-2073-1 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:424 | 424 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-121 | 69761-121-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-400 | 70092-400-43 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1013 | 73013-1013-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1081 | 73013-1081-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:424 | 424 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9227 | 71266-9227-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:425 | 425 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone/Bromfenac | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:425 | 425 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Coal Tar; Salicylic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:425 | 425 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-020 | 69761-020-01 | Estradiol | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:425 | 425 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:425 | 425 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-180 | 70092-180-79 | Fentanyl Citrate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-32 | Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-201 | 69761-201-01 | Estradiol | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fentanyl Citrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-07 | Fentanyl Citrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1023 | 73013-1023-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:425 | 425 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9225 | 71266-9225-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:426 | 426 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6514 | 72934-6514-2 | Mokura | 2025-1 | valid | 0 | 2026-09-18 |